Pillar Biosciences Partners with MSK to Enhance Precision Oncology with OncoKB™ Integration

CytoMed and SunAct Partner to Advance Allogeneic Gamma Delta T Cell Therapy in India

China’s NMPA Approves Astellas’ Zolbetuximab for Advanced Gastric and GEJ Cancer

Renovaro to Acquire Predictive Oncology in All-Stock Deal

Portage Biotech Relaunches Subsidiary as Cyncado Therapeutics to Advance Next-Generation Immuno-Oncology Therapies

ADSCC Pioneers Clinical-Grade iPSCs, Advancing Regenerative Medicine in the Middle East

Atavistik Bio Collaborates with Pfizer to Advance Precision Allosteric Therapeutics

European Commission Approves Amivantamab-Lazertinib Combination for First-Line Treatment of EGFR-Mutated NSCLC

Sangamo Therapeutics Regains Rights to Hemophilia A Gene Therapy Following Pfizer Exit

Innovent Biologics Collaborates with Roche to Advance DLL3 ADC Candidate IBI3009

CARsgen Therapeutics Announces Positive Phase II Results for Satricabtagene Autoleucel in Gastric Cancer

IDEAYA Biosciences and Hengrui Pharma Collaborate on Novel DLL3-Targeting ADC for Precision Oncology

Novartis Reports Positive Phase III STEER Study Results for OAV101 IT in SMA Type 2 Patients

Digital Pathology Biomarkers: Transforming Precision Oncology Diagnostics and Treatment

DATROWAY® Approved in Japan for HR Positive, HER2 Negative Breast Cancer

Home
/
update
/
details

Zscale Labs™ Introduces Revolutionary Neuromorphic AI for Medical Imaging

NextEdge Admin

20 Jul 2024

1 min 37 sec

Zscale Labs™ is thrilled to unveil its revolutionary Neuromorphic AI, a cutting-edge tool poised to transform medical diagnostics through multi-label Chest X-Ray image classification. This innovative technology showcases Zscale Labs™'s commitment to advancing healthcare with cognitive computing.

Accurate and timely diagnosis, particularly for respiratory conditions, is paramount. Our state-of-the-art tool harnesses the power of Zscale Labs™ Hyperdimensional Computing (HDC) and deep learning, aiding radiologists and healthcare providers in diagnosing multiple chest conditions from X-ray images. This leads to improved patient outcomes and highlights the transformative potential of AI in precision medicine.

Key features of our Neuromorphic AI include:

- Advanced Spatial Transformer Network (STN): Enhances image analysis precision by focusing on relevant X-ray areas.
- Hyperdimensional Computing (HDC) Encoding: Operates in a high-dimensional space for superior pattern recognition and accurate multi-label classification.

Zscale Labs™'s brain-inspired approach provides medical professionals with intricate details crucial for precise diagnosis, improving diagnostic accuracy and significantly reducing analysis time. This technology is an invaluable asset in modern healthcare.